Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Corneal Collagen Cross-linking for Progressive Keratoconus

ClinicalTrials.gov ID: NCT00647699

Public ClinicalTrials.gov record NCT00647699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus

Study identification

NCT ID
NCT00647699
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Glaukos Corporation
Industry
Enrollment
147 participants

Conditions and interventions

Interventions

  • riboflavin ophthalmic solution Drug
  • UVA Irradiation Device

Drug · Device

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Mar 31, 2011
Completion
Mar 31, 2011
Last update posted
Apr 25, 2021

2007 – 2011

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Shiley Eye Center La Jolla California 92093
Gordon -Weiss Vision Institute San Diego California 91222
Center for Excellence in Eye Care Miami Florida 33176
Price Vision Group Indianapolis Indiana 46260
Durrie Vision Kansas City Kansas 66211
Wilmer Eye Institute at Johns Hopkins University Baltimore Maryland 21287
Minnesota Eye Consultants Minneapolis Minnesota 55404
Cornea & Laser Eye Institute; Hersh Vision Group Teaneck New Jersey 07666
Edward Harkness Eye Institute at Columbia University Medical Center New York New York 10032
Ophthalmic Consultants of Long Island Rockville Centre New York 11570

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00647699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00647699 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →